Hakutulokset - Arkenau, Hendrik‐Tobias

Tarkenna hakua
  1. 1
    Novel Treatments for Metastatic Cutaneous Melanoma and the Management of Emergent Toxicities

    Novel Treatments for Metastatic Cutaneous Melanoma and the Management of Emergent Toxicities Tekijä Lemech, Charlotte, Arkenau, Hendrik-Tobias

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti Hae kokoteksti
    Teksti
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Biomarkers in Advanced Colorectal Cancer: Challenges in Translating Clinical Research into Practice

    Biomarkers in Advanced Colorectal Cancer: Challenges in Translating Clinical Research into Practice Tekijä Lemech, Charlotte, Arkenau, Hendrik-Tobias

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti Hae kokoteksti
    Teksti
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Combination Therapies for the Treatment of Advanced Melanoma: A Review of Current Evidence

    Combination Therapies for the Treatment of Advanced Melanoma: A Review of Current Evidence Tekijä Voskoboynik, Mark, Arkenau, Hendrik-Tobias

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti Hae kokoteksti
    Teksti
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Rationally designed treatment for metastatic colorectal cancer: Current drug development strategies

    Rationally designed treatment for metastatic colorectal cancer: Current drug development strategies Tekijä Spiliopoulou, Pavlina, Arkenau, Hendrik-Tobias

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti Hae kokoteksti
    Teksti
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities

    Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities Tekijä Fontana, Elisa, Arkenau, Hendrik-Tobias

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti Hae kokoteksti
    Teksti
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    The potential for BRAF V600 inhibitors in advanced cutaneous melanoma: rationale and latest evidence

    The potential for BRAF V600 inhibitors in advanced cutaneous melanoma: rationale and latest evidence Tekijä Lemech, Charlotte, Infante, Jeffrey, Arkenau, Hendrik-Tobias

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti Hae kokoteksti
    Teksti
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Advanced gastric cancer: Is there enough evidence to call second-line therapy standard?

    Advanced gastric cancer: Is there enough evidence to call second-line therapy standard? Tekijä Arkenau, Hendrik-Tobias, Saggese, Matilde, Lemech, Charlotte

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti Hae kokoteksti
    Teksti
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment

    Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment Tekijä Mak, Gabriel, Arkenau, Hendrik-Tobias, Chin, Melvin

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti Hae kokoteksti
    Teksti
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Clinical Impact of Checkpoint Inhibitors as Novel Cancer Therapies

    Clinical Impact of Checkpoint Inhibitors as Novel Cancer Therapies Tekijä Shih, Kent, Arkenau, Hendrik-Tobias, Infante, Jeffrey R.

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti Hae kokoteksti
    Teksti
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Recent Progress in the Systemic Treatment of Advanced/Metastatic Cholangiocarcinoma

    Recent Progress in the Systemic Treatment of Advanced/Metastatic Cholangiocarcinoma Tekijä Fostea, Raluca Maria, Fontana, Elisa, Torga, Gonzalo, Arkenau, Hendrik-Tobias

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti Hae kokoteksti
    Teksti
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Research Biopsies in the Context of Early Phase Oncology Studies: Clinical and Ethical Considerations

    Research Biopsies in the Context of Early Phase Oncology Studies: Clinical and Ethical Considerations Tekijä Saggese, Matilde, Dua, Divyanshu, Simmons, Emily, Lemech, Charlotte, Arkenau, Hendrik-Tobias

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti Hae kokoteksti
    Teksti
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancer

    Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancer Tekijä Moschetta, Michele, Mak, Gabriel, Hauser, Joana, Davies, Catriona, Uccello, Mario, Arkenau, Hendrik-Tobias

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti Hae kokoteksti
    Teksti
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Signal pathways and precision therapy of small-cell lung cancer

    Signal pathways and precision therapy of small-cell lung cancer Tekijä Yuan, Min, Zhao, Yu, Arkenau, Hendrik-Tobias, Lao, Tongnei, Chu, Li, Xu, Qing

    Julkaistu 2022
    Hae kokoteksti Hae kokoteksti Hae kokoteksti
    Teksti
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    KRAS and BRAF Mutations in Stage II and III Colon Cancer: A Systematic Review and Meta-Analysis

    KRAS and BRAF Mutations in Stage II and III Colon Cancer: A Systematic Review and Meta-Analysis Tekijä Formica, Vincenzo, Sera, Francesco, Cremolini, Chiara, Riondino, Silvia, Morelli, Cristina, Arkenau, Hendrik-Tobias, Roselli, Mario

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti Hae kokoteksti
    Teksti
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Perceptions and Referral Trends into Phase I Oncology Trials: Results of a Clinical Survey

    Perceptions and Referral Trends into Phase I Oncology Trials: Results of a Clinical Survey Tekijä Brunetto, Andre, Olmos, David, Arkenau, Hendrik-Tobias, Tan, Daniel, Yap, Timomy, de Bono, Johann, Barriuso, Jorge, Kaye, Stan

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti Hae kokoteksti
    Teksti
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 Blockade

    Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 Blockade Tekijä Moschetta, Michele, Uccello, Mario, Kasenda, Benjamin, Mak, Gabriel, McClelland, Anissa, Boussios, Stergios, Forster, Martin, Arkenau, Hendrik-Tobias

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti Hae kokoteksti
    Teksti
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT

    Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT Tekijä Hughes, Andrew, Landers, Donal, Arkenau, Hendrik-Tobias, Shah, Saj, Stephens, Richard, Mahal, Amrik, Simmons, Matthew, Lemech, Charlotte, Royle, Jennifer

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti Hae kokoteksti
    Teksti
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT

    Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT Tekijä Hughes, Andrew, Landers, Donal, Arkenau, Hendrik-Tobias, Shah, Saj, Stephens, Richard, Mahal, Amrik, Simmons, Matthew, Lemech, Charlotte, Royle, Jennifer

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti Hae kokoteksti
    Teksti
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Evaluation of CYP3A‐mediated drug–drug interactions with romidepsin in patients with advanced cancer

    Evaluation of CYP3A‐mediated drug–drug interactions with romidepsin in patients with advanced cancer Tekijä Laille, Eric, Patel, Manish, Jones, Suzanne F., Burris, Howard A., Infante, Jeffrey, Lemech, Charlotte, Liu, Liangang, Arkenau, Hendrik‐Tobias

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti Hae kokoteksti
    Teksti
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Mammographic Breast Density and Urbanization: Interactions with BMI, Environmental, Lifestyle, and Other Patient Factors

    Mammographic Breast Density and Urbanization: Interactions with BMI, Environmental, Lifestyle, and Other Patient Factors Tekijä Perry, Nick, Moss, Sue, Dixon, Steve, Milner, Sue, Mokbel, Kefah, Lemech, Charlotte, Arkenau, Hendrik-Tobias, Duffy, Stephen, Pinker, Katja

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti Hae kokoteksti
    Teksti
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: